El Segundo, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)PANCREATIC CANCER ACTION NETWORK INC, founded in 1999, is a mid-sized nonprofit in the Diseases & Disorders sector that reported $47.1M in total revenue in fiscal year 2023. Revenue fell 39% from the prior year — a significant decline worth monitoring. Expenses of $60.5M exceeded revenue, resulting in a 29% operating deficit.
OUR MISSION IS TO TAKE BOLD ACTION TO IMPROVE THE LIVES OF EVERYONE IMPACTED BY PANCREATIC CANCER BY ADVANCING SCIENTIFIC RESEARCH, BUILDING COMMUNITY, SHARING KNOWLEDGE, AND ADVOCATING FOR PATIENTS.
RESEARCH & SCIENTIFIC AFFAIRS - PANCAN FUNDS GROUNDBREAKING RESEARCH INITIATIVES THAT WILL TRANSFORM THE WAY PANCREATIC CANCER IS DETECTED AND TREATED. WE FUND RESEARCH GRANTS TO INDIVIDUAL...
RESEARCH & SCIENTIFIC AFFAIRS - PANCAN FUNDS GROUNDBREAKING RESEARCH INITIATIVES THAT WILL TRANSFORM THE WAY PANCREATIC CANCER IS DETECTED AND TREATED. WE FUND RESEARCH GRANTS TO INDIVIDUAL INVESTIGATORS AND LARGE-SCALE, MULTI-INSTITUTIONAL CLINICAL PROJECTS THAT ARE FOCUSED ON ADVANCING NEW TREATMENTS AND EARLY DETECTION FOR PANCREATIC CANCER. WE INVESTED A RECORD $27.3 MILLION IN RESEARCH & SCIENTIFIC AFFAIRS IN FISCAL YEAR 2024.OUR RESEARCH FUNDING SUPPORTED IMPORTANT RESEARCH PROJECTS AT INSTITUTIONS ACROSS THE COUNTRY, AND PANCAN'S PRECISION PROMISE ADAPTIVE CLINICAL TRIAL, EARLY DETECTION INITIATIVE, KNOW YOUR TUMOR PRECISION MEDICINE SERVICE, AND PATIENT REGISTRY. SINCE 2003 PANCAN HAS AWARDED 237 RESEARCH GRANTS TO 217 SCIENTISTS AT 78 INSTITUTIONS. PANCAN'S CUMULATIVE RESEARCH INVESTMENT IS NOW MORE THAN $235 MILLION, MAKING A SIGNIFICANT IMPACT ON THE DIAGNOSIS, TREATMENT AND CARE OF TODAY'S PATIENTS AND THOSE WHO WILL BE DIAGNOSED IN THE FUTURE.
COMMUNITY ENGAGEMENT - NEARLY 60 VOLUNTEER-LED AFFILIATES WITH MORE THAN 3,220 VOLUNTEERS RAISE AWARENESS OF PANCAN AND THE DISEASE AND EDUCATE THEIR COMMUNITIES ABOUT PANCREATIC CANCER. VOLUNTEERS...
COMMUNITY ENGAGEMENT - NEARLY 60 VOLUNTEER-LED AFFILIATES WITH MORE THAN 3,220 VOLUNTEERS RAISE AWARENESS OF PANCAN AND THE DISEASE AND EDUCATE THEIR COMMUNITIES ABOUT PANCREATIC CANCER. VOLUNTEERS HOSTED NEARLY 60 PURPLESTRIDE EVENTS ACROSS THE COUNTRY THIS YEAR, WITH 62,525 PARTICIPANTS REGISTERED SUPPORTING SURVIVORS, FAMILIES AND FRIENDS, AS WELL AS PROVIDING EDUCATIONAL INFORMATION AT THE EVENTS. PURPLESTRIDE PARTICIPANTS RAISED MORE THAN $16 MILLION IN FISCAL YEAR 2024. WE ARE ALSO A FOUNDING MEMBER OF THE WORLD PANCREATIC CANCER COALITION, COMPOSED OF MORE THAN 100 PANCREATIC CANCER PATIENT ADVOCACY GROUPS FROM MORE THAN 30 COUNTRIES AND SIX CONTINENTS. THE COALITION HAS AN ONGOING COMMITMENT TO CONTINUING EDUCATION FOR ITS MEMBERS AND HOSTS WORLD PANCREATIC CANCER DAY EVERY NOVEMBER TO RAISE GLOBAL AWARENESS OF THE DISEASE.
PATIENT SERVICES - PROVIDES FREE, PERSONALIZED INFORMATION AND RESOURCES ABOUT PANCREATIC CANCER, TREATMENT OPTIONS, CLINICAL TRIALS, DIET AND NUTRITION, SPECIALISTS AND SUPPORT RESOURCES TO HELP...
PATIENT SERVICES - PROVIDES FREE, PERSONALIZED INFORMATION AND RESOURCES ABOUT PANCREATIC CANCER, TREATMENT OPTIONS, CLINICAL TRIALS, DIET AND NUTRITION, SPECIALISTS AND SUPPORT RESOURCES TO HELP PATIENTS, CAREGIVERS AND HEALTHCARE PROVIDERS. WE HAVE THE LARGEST, MOST UP-TO-DATE CLINICAL TRIALS DATABASE IN THE COUNTRY AND PROVIDE CONSTITUTENTS WITH PERSONALIZED SEARCHES SO THAT THEY UNDERSTAND ALL OF THEIR TREATMENT OPTIONS. OUR EXPERT PATIENT SERVICES CASE MANAGERS SHARE MORE RESOURCES AND SPEAK WITH MORE PANCREATIC CANCER PATIENTS THAN ANY OTHER ORGANIZATION IN THE WORLD. LAST YEAR ALONE, WE HAD NEARLY 70,000 INTERACTIONS WITH PATIENTS WITH PANCREATIC CANCER, THEIR FAMILIES, CAREGIVERS AND HEALTHCARE PROFFESSIONALS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $47,081,538 | $77,560,417 | -0.4% |
| Expenses | $60,542,930 | $69,713,692 | -0.1% |
| Net Income | $-13,461,392 | $7,846,725 | -2.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| N/A | PRESIDENT & CEO/DIRECTOR | 50.0 |
Officer
Director
|
$688,005 | $91,501 | $779,506 |
| N/A | VICE CHAIRMAN | 2.0 |
Officer
Director
|
$0 | $0 | $0 |
| N/A | CHAIRMAN | 2.0 |
Officer
Director
|
$0 | $0 | $0 |
| N/A | BOARD MEMBER | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | BOARD MEMBER | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | BOARD MEMBER | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | BOARD MEMBER (through 11/23) | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | BOARD MEMBER | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | BOARD MEMBER | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | BOARD MEMBER | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | BOARD MEMBER | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | BOARD MEMBER | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | Board Member | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | BOARD MEMBER | 2.0 |
Director
|
$0 | $0 | $0 |
| N/A | CHIEF FINANCIAL & Business Operations Officer | 50.0 |
Officer
|
$347,118 | $80,133 | $427,251 |
| N/A | CHIEF PEOPLE OFFICER | 50.0 |
Key Emp
|
$334,103 | $48,169 | $382,272 |
| N/A | CHIEF SCIENCE OFFICER | 50.0 |
Key Emp
|
$355,887 | $76,499 | $432,386 |
| N/A | CHIEF BUSINESS OFFICER | 50.0 |
Key Emp
|
$386,656 | $55,462 | $442,118 |
| N/A | VP of Clinical Operations (through 1/24) | 50.0 |
Highest
|
$280,307 | $66,017 | $346,324 |
| N/A | Senior VP & GM, Precision Promise (through 1/24) | 50.0 |
Highest
|
$404,533 | $40,759 | $445,292 |
| N/A | CHIEF MARKETING AND COMMUNICATION (through 6/24) | 50.0 |
Highest
|
$325,181 | $53,938 | $379,119 |
| N/A | SENIOR VICE PRESIDENT, DEVELOPMENT ( through 6/24) | 50.0 |
Highest
|
$297,700 | $57,935 | $355,635 |
| N/A | VP of National Leadership Giving | 50.0 |
Highest
|
$270,069 | $50,538 | $320,607 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $47,081,538 | $60,542,930 | $56,273,833 | $-13,461,392 |
| 2023 | $77,560,417 | $69,713,692 | $80,600,372 | $7,846,725 |
| 2022 | $50,694,126 | $54,532,405 | $65,833,440 | $-3,838,279 |
| 2022 | $52,930,843 | $52,685,332 | $68,159,698 | $245,511 |
| 2021 | $44,852,538 | $40,886,619 | $68,087,532 | $3,965,919 |
| 2020 | $36,637,275 | $42,324,633 | $60,854,270 | $-5,687,358 |
| 2019 | $41,700,282 | $35,978,054 | $65,075,415 | $5,722,228 |
Compare PANCREATIC CANCER ACTION NETWORK INC with other nonprofits in California and across the country.